FineMark National Bank & Trust Acquires New Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

FineMark National Bank & Trust bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,415 shares of the financial services provider’s stock, valued at approximately $319,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. HHM Wealth Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 150 shares in the last quarter. VSM Wealth Advisory LLC acquired a new stake in iShares Biotechnology ETF in the fourth quarter worth approximately $30,000. Bradley & Co. Private Wealth Management LLC bought a new position in iShares Biotechnology ETF during the 4th quarter valued at $32,000. Newbridge Financial Services Group Inc. acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at $33,000. Finally, Hager Investment Management Services LLC acquired a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $131.14 on Thursday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The company has a market capitalization of $6.20 billion, a P/E ratio of 27.83 and a beta of 0.84. The company’s 50 day simple moving average is $136.23 and its 200 day simple moving average is $139.11.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were issued a $0.1212 dividend. The ex-dividend date was Tuesday, March 18th. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.